PBS Biotech logo — Next Generation Single-Use Bioreactors

PBS Biotech

Next Generation Single-Use Bioreactors

Founded 2008 United States Camarillo, United States 100 employees Venture round Total: $32.00M Biotechnology, Health Care +2

General Information

Company Name PBS Biotech
Founded Year 2008
Location United States Camarillo, United States
Employees 100
Industries Biotechnology, Health Care, Medical Devices +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with PBS Biotech. To contact PBS Biotech, visit pbsbiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About PBS Biotech

PBS Biotech is a biotechnology startup founded in 2006 and headquartered in the United States. The company's slogan, "Next Generation Single-Use Bioreactors," accurately represents its focus on providing innovative, single-use bioreactor systems tailored for cultivating shear-sensitive cell types for cell therapy development. PBS Biotech offers scalable, cost-effective disposable solutions designed to support the transition from benchtop R&D to large-scale cGMP manufacturing. In addition to its product offerings, the company provides expert process development services aimed at addressing cell culture challenges and expediting the path to commercialization. The latest investment received by PBS Biotech was a substantial $22.00M Venture Round investment on 09 January 2023, with BroadOak Capital Partners and Avego Management participating as the investors. PBS Biotech's commitment to addressing critical needs within the bioreactor systems space positions it as an attractive prospect for venture capitalists looking to invest in the biotechnology, healthcare, and pharmaceutical industries. For further information on PBS Biotech, interested parties can contact the sales team at [email protected] or visit the website at www.pbsbiotech.com.

Taxonomy: Single-use bioreactors, Bioprocess solutions, Process development services, Cell therapy solutions, cGMP production, USP Class VI plastics, iPSCs, MSCs, Pluripotent stem cells, Mesenchymal stem cells, Stem cells, Scale-up, 3D cell culture

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $22.00M 2
BroadOak Capital Partners, Avego Management
09 Jan 2023
Venture Round $10.00M 1
BroadOak Capital Partners
16 Aug 2021

PBS Biotech Alternatives & Competitors

View All Alternatives
PBS Biotech vs

Your Cell-Therapy Specialized CDMO

35 employees
Biotechnology, Health Care
PBS Biotech vs

Scalable single-use bioreactors.

Seed
4 employees
Biotechnology, Health Care
PBS Biotech vs

Cell Culture Reimagined

Series A
10 employees
Biotechnology, Medical Devices

FAQ About PBS Biotech

Next Generation Single-Use Bioreactors
PBS Biotech was founded in 2008.
PBS Biotech is headquartered in Camarillo, United States.
PBS Biotech operates in Biotechnology, Health Care, Medical Devices and Pharmaceutical. Its work centres on Single-use bioreactors, Bioprocess solutions, Process development services and Cell therapy solutions.
PBS Biotech has approximately 100 employees.
PBS Biotech has completed 2 funding rounds, raising a total of $32.00M. The latest funding stage is Venture round.
Top alternatives and competitors to PBS Biotech include Cell-Easy, Membio Inc., CellFiber, LumaCyte, PuREC Co.Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PBS Biotech and Cell-Easy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PBS Biotech, https://bouncewatch.com/company/pbs-biotech, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes